40 related articles for article (PubMed ID: 26248108)
1. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
2. Mammogram and Pap Smear Uptake Among Women in the HIV Outpatient Study USA, 2010-2021.
Firnhaber C; Simoncini G; Mayer C; Armon C; Ewing AC; Tedaldi E; Battalora L; Carlson K; Chagaris K; Buchacz K; Li J
AIDS Patient Care STDS; 2024 Apr; 38(4):151-154. PubMed ID: 38656216
[No Abstract] [Full Text] [Related]
3. Chronic disease as a barrier to breast and cervical cancer screening.
Kiefe CI; Funkhouser E; Fouad MN; May DS
J Gen Intern Med; 1998 Jun; 13(6):357-65. PubMed ID: 9669564
[TBL] [Abstract][Full Text] [Related]
4. Increasing breast and cervical cancer screening in low-income women.
Margolis KL; Lurie N; McGovern PG; Tyrrell M; Slater JS
J Gen Intern Med; 1998 Aug; 13(8):515-21. PubMed ID: 9734787
[TBL] [Abstract][Full Text] [Related]
5. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data.
Moser K; Patnick J; Beral V
BMJ; 2009 Jun; 338():b2025. PubMed ID: 19531549
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and correlates of breast and cervical cancer screening among a Midwest community sample of low-acculturated Latinas.
Martínez-Donate AP; Vera-Cala LM; Zhang X; Vedro R; Angulo R; Atkinson T
J Health Care Poor Underserved; 2013 Nov; 24(4):1717-38. PubMed ID: 24185166
[TBL] [Abstract][Full Text] [Related]
7. U.S. Preventive Services Task Force recommendations and cancer screening among female Medicare beneficiaries.
Salloum RG; Kohler RE; Jensen GA; Sheridan SL; Carpenter WR; Biddle AK
J Womens Health (Larchmt); 2014 Mar; 23(3):211-7. PubMed ID: 24195774
[TBL] [Abstract][Full Text] [Related]
8. Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period Caused by the SARS-CoV-2 Virus: Ecological Study.
Costa AS; Baracat EC; Júnior JMS; Sorpreso ICE
Int J Environ Res Public Health; 2024 Mar; 21(3):. PubMed ID: 38541302
[TBL] [Abstract][Full Text] [Related]
9. Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
Ferreira HNC; Capistrano GN; Morais TNB; Costa KTDS; Quirino ALS; Costa RLPD; Andrade FB
PLoS One; 2023; 18(10):e0278011. PubMed ID: 37883452
[TBL] [Abstract][Full Text] [Related]
10. Breast and cervical cancer screening specific effects of depression and obesity.
Ludman EJ; Ichikawa LE; Simon GE; Rohde P; Arterburn D; Operskalski BH; Linde JA; Jeffery RW
Am J Prev Med; 2010 Mar; 38(3):303-10. PubMed ID: 20171532
[TBL] [Abstract][Full Text] [Related]
11. Determinants of a healthy lifestyle and use of preventive screening in Canada.
Qi V; Phillips SP; Hopman WM
BMC Public Health; 2006 Nov; 6():275. PubMed ID: 17090313
[TBL] [Abstract][Full Text] [Related]
12. An Online Survey and Focus Groups for Promoting Cancer Prevention Measures.
Shah SK; Jones-Carr M; Bimali M; Su LJ; Nakagawa M
J Cancer Educ; 2022 Dec; 37(6):1782-1789. PubMed ID: 34046818
[TBL] [Abstract][Full Text] [Related]
13. Delay in diagnosis of oral cancer: a systematic review.
Lima AM; Meira IA; Soares MS; Bonan PR; Mélo CB; Piagge CS
Med Oral Patol Oral Cir Bucal; 2021 Nov; 26(6):e815-e824. PubMed ID: 34704975
[TBL] [Abstract][Full Text] [Related]
14. Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.
Barrios C; Freitas-Junior R; Martins S; Bines J; Estevez-Diz MDP; Caleffi M
JCO Glob Oncol; 2021 Apr; 7():474-485. PubMed ID: 33822641
[TBL] [Abstract][Full Text] [Related]
15. Trends in the Incidence of Breast Cancer Following the Radiological Accident in Goiânia: A 25-Year Analysis.
Rahal RMS; Rocha ME; Freitas-Junior R; Correa RDS; Rodrigues D; Martins E; Soares LR; Oliveira JC
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3811-3816. PubMed ID: 31870126
[TBL] [Abstract][Full Text] [Related]
16. Cytology-Based Screening During Antenatal Care as a Method for Preventing Cervical Cancer.
Monteiro PB; Monteiro Filho MP; de Figueirêdo JT; Saintrain MVL; Bruno ZV; Carvalho FHC
Asian Pac J Cancer Prev; 2017 Sep; 18(9):2513-2518. PubMed ID: 28952289
[TBL] [Abstract][Full Text] [Related]
17. Quality of cervical cancer screening in Brazil: external assessment of the PMAQ.
Barcelos MRB; Lima RCD; Tomasi E; Nunes BP; Duro SMS; Facchini LA
Rev Saude Publica; 2017 Jul; 51():67. PubMed ID: 28746576
[TBL] [Abstract][Full Text] [Related]
18. Patterns of cervical cytological abnormalities according to the Human Development Index in the northeast region of Brazil.
Pinho-França JR; Chein MBDC; Thuler LCS
BMC Womens Health; 2016 Aug; 16():54. PubMed ID: 27516107
[TBL] [Abstract][Full Text] [Related]
19. [Human Development Index and secondary prevention of breast and cervical cancer: an ecological study].
Sadovsky AD; Poton WL; Reis-Santos B; Barcelos MR; Silva IC
Cad Saude Publica; 2015 Jul; 31(7):1539-50. PubMed ID: 26248108
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
